The size of the Smart Pill Technologies Market in APAC was worth USD 677 Million in 2021 and is projected to reach USD 1588 Million by 2026, growing at a CAGR of 18.4% during the forecast period from 2021 to 2026.
Smart Pill Technologies is the use of advanced methods for the preparation of prescription pills which has revolutionized patient monitoring, diagnosis of diseases and improved drug delivery. Smart pill technologies are the converging link between digital technology and healthcare industries. These smart pills have many benefits other than providing signals and alerts when consumed.
The market for Smart Pill Technologies is mainly driven due to willingness from the patients to opt for this treatment, easy tracking of the bodily functions and managing prescriptions and overall health. Also, factors such as wireless health monitoring and site-specific drug delivery are expected to favor the adoption of these technologies by patients and physicians. But, the market growth can be hampered due to the technological incompetence of capsule endoscopes, high costs, and fear among patients regarding swallowing a microchip.
This research report on the Asia Pacific Smart Pill Technologies Market has been segmented and sub-segmented into the following categories.
By Application:
By Country:
On the basis of application, the Capsule endoscopy segment is expected to be one of the largest markets owing to the advantages attached such as disease diagnosis in the small intestine. The drug delivery market is also expected to experience growth due to the benefit of improving medication efficiencies, improving patient compliance & convenience, and fast-paced technology.
On the basis of region, the Smart Pill Technologies market in the Asia-Pacific region is projected to grow at the highest CAGR, which is greatly due to increasing reimbursements, training in endoscopes handling, and huge corporate investments in R&D in countries like Japan.
Noteworthy Companies dominating the Asia Pacific Smart Pill Technologies Market Profiled in the Report are CapsoVision, Inc., Given Imaging, Inc., Medimetrics S.A. de C.V., Olympus Corporation, Bio-Images Research Limited, Novartis, Given Imaging Ltd, Philips Healthcare, Smartpill, Inc., Medtronic, Inc., Pentax Medical Company, Siemens Healthcare, Stryker Corporation, GE Healthcare, Boston Scientific Corporation, IntroMedic Inc., Chongqing Jinshan Science & Technology Group Co. Ltd., Proteus Digital Health Inc.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Application
5.1.1 Introduction
5.1.2 Capsule Endoscopy
5.1.2.1 Small Bowel Video Capsule Endoscopy
5.1.2.2 Colon Capsule Endoscopy
5.1.2.3 OMOM Capsule Endoscopy Platform
5.1.2.4 MiroCam
5.1.2.5 Upgraded MiroCam and Advanced Capsule Endoscope
5.1.2.6 The ANKON MCE System
5.1.2.7 CapsoCam
5.1.3 Drug Delivery
5.1.4 Patient monitoring
5.1.5 Y-o-Y Growth Analysis, By Application
5.1.6 Market Attractiveness Analysis, By Application
5.1.7 Market Share Analysis, By Application
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Application
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Application
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Application
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 CapsoVision, Inc.
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Given Imaging, Inc.
8.3 Medimetrics S.A. de C.V.
8.4 Olympus Corporation
8.5 Bio-Images Research Limited
8.6 Novartis
8.7 Given Imaging Ltd
8.8 Philips Healthcare
8.9 Smartpill, Inc.
8.10 Medtronic, Inc.
8.11 Pentax Medical Company
8.12 Siemens Healthcare
8.13 Stryker Corporation
8.14 GE Healthcare
8.15 Boston Scientific Corporation
8.16 IntroMedic Inc.
8.17 Chongqing Jinshan Science & Technology Group Co. Ltd.
8.18 Proteus Digital Health Inc.
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
